Insulet
PODD
525 hedge funds and large institutions have $20.6B invested in Insulet in 2022 Q4 according to their latest regulatory filings, with 103 funds opening new positions, 159 increasing their positions, 196 reducing their positions, and 39 closing their positions.
164% more first-time investments, than exits
New positions opened: 103 | Existing positions closed: 39
50% more funds holding in top 10
Funds holding in top 10: 6 → 9 (+3)
26% more capital invested
Capital invested by funds: $16.3B → $20.6B (+$4.31B)
12% more funds holding
Funds holding: 467 → 525 (+58)
1.46% less ownership
Funds ownership: 102.59% → 101.14% (-1.5%)
19% less repeat investments, than reductions
Existing positions increased: 159 | Existing positions reduced: 196
41% less call options, than puts
Call options by funds: $57.1M | Put options by funds: $96.5M
Top Buyers
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
+$154M |
| 2 |
BlackRock
New York
|
+$120M |
| 3 |
American Century Companies
Kansas City,
Missouri
|
+$49.5M |
| 4 |
Invesco
Atlanta,
Georgia
|
+$45.7M |
| 5 |
SI
Scout Investments
Kansas City,
Missouri
|
+$42.5M |
Top Sellers
PODD Hedge Fund Activity: Q4 2022 in Review
525 of the 6,221 institutional investors tracked by Wall St. Rank reported a position in Insulet (PODD) for Q4 2022, worth a combined $20.6B — up 26% from $16.3B a quarter earlier.
Buyers outnumbered sellers: 103 funds opened new PODD positions and 39 closed out — a net gain of 64 holders — while 159 added to existing stakes and 196 trimmed.
The largest buyer was Wellington Management Group, adding an estimated $154M. The largest seller was Primecap Management, cutting an estimated $98.2M.
- 525 institutional investors held Insulet (PODD) as of Q4 2022, up from 467 in Q3 2022.
- Funds reported $20.6B of Insulet stock for Q4 2022, up 26% quarter-over-quarter.
- 103 funds opened new Insulet positions in Q4 2022 and 39 closed out, a net change of +64 holders.
- The largest Insulet buyer in Q4 2022 was Wellington Management Group, an estimated $154M added.
- The largest Insulet seller in Q4 2022 was Primecap Management, an estimated $98.2M sold.
Based on aggregated 13F filings for Q4 2022.